PFE vs VRT: Which Is the Better Buy?

Side-by-side comparison of Pfizer Inc. and Vertiv Holdings Co β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-05-05.
Pfizer Inc. Β· Healthcare
$26.33
+28.6% upside to fair value
Grade B
VS
Vertiv Holdings Co Β· Industrials
$305.14
-45.0% upside to fair value
Grade D High Quality
QuantHub Verdict
PFE has more upside to fair value (+28.6%). PFE trades at a lower forward P/E (19.3x). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric PFE VRT
Current Price $26.33 $305.14
Fair Value Estimate $33.85 $167.83
Upside to Fair Value +28.6% -45.0%
Market Cap $149.8B $116.8B
Forward P/E 19.3x 75.0x
EV / EBITDA 12.9x 50.1x
Price / Sales 2.4x 10.8x
Price / FCF 16.5x 50.5x
Revenue Growth YoY -1.2% +30.1%
Gross Margin 70.3% 36.2%
Operating Margin 24.7% 18.5%
Return on Equity 8.7% 42.1%
Dividend Yield 0% 0%
FCF Yield 6.06% 1.98%
Analyst Consensus Hold Strong Buy
Investment Thesis
PFE β€” Pfizer Inc.
Pfizer Inc. is a leading global pharmaceutical company specializing in drug manufacturing with a strong presence in vaccines, oncology, and primary care. The company benefits from a seasoned leadership team under CEO Albert Bourla, who has driven a strategic transformation focusing on science-driven innovation and portfolio optimization. Despite a high gross margin of 70.3% and solid operating ma…
VRT β€” Vertiv Holdings Co
Vertiv Holdings Co operates in the electrical equipment and parts industry within the industrials sector, focusing on critical digital infrastructure technology products and services. The company has demonstrated strong business quality with a 42.1% return on equity, 30.1% revenue growth, and 137.1% earnings growth in the most recent quarter, supported by solid margins including a 36.2% gross mar…
Accumulation Zones
Metric PFE VRT
Zone Low $25.39 $125.87
Zone High $28.77 $142.66
In Buy Zone? Yes No
← PFE Research    VRT Research β†’    All Research